Glucan synthase — Drug Target
All drugs that target Glucan synthase — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- MK0991, caspofungin acetate · Merck Sharp & Dohme LLC · Echinocandin · Infectious Disease
Inhibits the synthesis of beta-1,3-D-glucan, a critical component of fungal cell walls.